OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
Xiaoting Wei, Zhengyun Zou, Weizhen Zhang, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114008-114008
Closed Access | Times Cited: 6
Xiaoting Wei, Zhengyun Zou, Weizhen Zhang, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114008-114008
Closed Access | Times Cited: 6
Showing 6 citing articles:
Global, regional, and national trends in the burden of melanoma and non-melanoma skin cancer: insights from the global burden of disease study 1990–2021
Lei Zhou, Yun Zhong, Le Han, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Lei Zhou, Yun Zhong, Le Han, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Size-specific clonidine-loaded liposomes: Advancing melanoma microenvironment suppression with safety and precision
Nianzhou Yu, Yantao Xu, Qi Sun, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 120-134
Closed Access
Nianzhou Yu, Yantao Xu, Qi Sun, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 120-134
Closed Access
Characterization of 13 Unknown Photodegradation Product of Tunlametinib Capsules by Liquid Chromatography Coupled with Ion Trap/Time-of-Flight Mass Spectrometry
Ying Yang, Jiarui Gao, Hongxia Zeng
(2025)
Closed Access
Ying Yang, Jiarui Gao, Hongxia Zeng
(2025)
Closed Access
New Drugs Approved by the NMPA in 2024: Synthesis and Clinical Applications
Xinxin Zhao, Yuan Lin, Zheng Gong, et al.
European Journal of Medicinal Chemistry (2025) Vol. 291, pp. 117643-117643
Closed Access
Xinxin Zhao, Yuan Lin, Zheng Gong, et al.
European Journal of Medicinal Chemistry (2025) Vol. 291, pp. 117643-117643
Closed Access
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma
Jiaran Zhang, Huichun Tian, Lili Mao, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 905-916
Open Access
Jiaran Zhang, Huichun Tian, Lili Mao, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 905-916
Open Access
Tunlametinib: First Approval
Susan J. Keam
Drugs (2024) Vol. 84, Iss. 8, pp. 1005-1010
Closed Access | Times Cited: 3
Susan J. Keam
Drugs (2024) Vol. 84, Iss. 8, pp. 1005-1010
Closed Access | Times Cited: 3
Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model
Sara Mathlouthi, Łukasz Kuryk, Marta Prygiel, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 777-793
Open Access | Times Cited: 2
Sara Mathlouthi, Łukasz Kuryk, Marta Prygiel, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 777-793
Open Access | Times Cited: 2
